nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—Ileus paralytic—Vinblastine—testicular cancer	0.0718	0.0718	CcSEcCtD
Benzatropine—Ileus—Vinblastine—testicular cancer	0.0439	0.0439	CcSEcCtD
Benzatropine—Ileus—Ifosfamide—testicular cancer	0.0317	0.0317	CcSEcCtD
Benzatropine—Cerebrovascular accident—Vinblastine—testicular cancer	0.023	0.023	CcSEcCtD
Benzatropine—Appetite absent—Methotrexate—testicular cancer	0.0213	0.0213	CcSEcCtD
Benzatropine—Disorientation—Bleomycin—testicular cancer	0.0213	0.0213	CcSEcCtD
Benzatropine—Cerebrovascular accident—Bleomycin—testicular cancer	0.0194	0.0194	CcSEcCtD
Benzatropine—Body temperature increased—Carboplatin—testicular cancer	0.0186	0.0186	CcSEcCtD
Benzatropine—Disorientation—Ifosfamide—testicular cancer	0.0182	0.0182	CcSEcCtD
Benzatropine—Psychotic disorder—Ifosfamide—testicular cancer	0.0159	0.0159	CcSEcCtD
Benzatropine—Hypoaesthesia—Vinblastine—testicular cancer	0.0155	0.0155	CcSEcCtD
Benzatropine—Urinary retention—Ifosfamide—testicular cancer	0.0155	0.0155	CcSEcCtD
Benzatropine—Dysphagia—Dactinomycin—testicular cancer	0.0153	0.0153	CcSEcCtD
Benzatropine—Cerebrovascular accident—Cisplatin—testicular cancer	0.0143	0.0143	CcSEcCtD
Benzatropine—Ileus—Epirubicin—testicular cancer	0.014	0.014	CcSEcCtD
Benzatropine—Dysuria—Ifosfamide—testicular cancer	0.0131	0.0131	CcSEcCtD
Benzatropine—Hypoaesthesia—Bleomycin—testicular cancer	0.0131	0.0131	CcSEcCtD
Benzatropine—Ileus—Doxorubicin—testicular cancer	0.013	0.013	CcSEcCtD
Benzatropine—Confusional state—Chlorambucil—testicular cancer	0.0122	0.0122	CcSEcCtD
Benzatropine—Dysphagia—Etoposide—testicular cancer	0.0111	0.0111	CcSEcCtD
Benzatropine—Decreased appetite—Chlorambucil—testicular cancer	0.0105	0.0105	CcSEcCtD
Benzatropine—Feeling abnormal—Chlorambucil—testicular cancer	0.00996	0.00996	CcSEcCtD
Benzatropine—Decreased appetite—Vinblastine—testicular cancer	0.00963	0.00963	CcSEcCtD
Benzatropine—Body temperature increased—Chlorambucil—testicular cancer	0.00956	0.00956	CcSEcCtD
Benzatropine—Constipation—Vinblastine—testicular cancer	0.00947	0.00947	CcSEcCtD
Benzatropine—Confusional state—Bleomycin—testicular cancer	0.00943	0.00943	CcSEcCtD
Benzatropine—Vision blurred—Ifosfamide—testicular cancer	0.00923	0.00923	CcSEcCtD
Benzatropine—Feeling abnormal—Vinblastine—testicular cancer	0.00913	0.00913	CcSEcCtD
Benzatropine—Hypersensitivity—Chlorambucil—testicular cancer	0.00891	0.00891	CcSEcCtD
Benzatropine—Hypoaesthesia—Etoposide—testicular cancer	0.00884	0.00884	CcSEcCtD
Benzatropine—Hypersensitivity—Vinblastine—testicular cancer	0.00816	0.00816	CcSEcCtD
Benzatropine—Decreased appetite—Bleomycin—testicular cancer	0.00813	0.00813	CcSEcCtD
Benzatropine—Confusional state—Ifosfamide—testicular cancer	0.00806	0.00806	CcSEcCtD
Benzatropine—Vision blurred—Cisplatin—testicular cancer	0.00796	0.00796	CcSEcCtD
Benzatropine—Cerebrovascular accident—Methotrexate—testicular cancer	0.00785	0.00785	CcSEcCtD
Benzatropine—Feeling abnormal—Bleomycin—testicular cancer	0.00771	0.00771	CcSEcCtD
Benzatropine—Vomiting—Chlorambucil—testicular cancer	0.00769	0.00769	CcSEcCtD
Benzatropine—Decreased appetite—Dactinomycin—testicular cancer	0.00759	0.00759	CcSEcCtD
Benzatropine—Body temperature increased—Bleomycin—testicular cancer	0.0074	0.0074	CcSEcCtD
Benzatropine—Cerebrovascular accident—Epirubicin—testicular cancer	0.00735	0.00735	CcSEcCtD
Benzatropine—Feeling abnormal—Dactinomycin—testicular cancer	0.00719	0.00719	CcSEcCtD
Benzatropine—Nausea—Chlorambucil—testicular cancer	0.00718	0.00718	CcSEcCtD
Benzatropine—Vomiting—Vinblastine—testicular cancer	0.00704	0.00704	CcSEcCtD
Benzatropine—Decreased appetite—Ifosfamide—testicular cancer	0.00695	0.00695	CcSEcCtD
Benzatropine—Body temperature increased—Dactinomycin—testicular cancer	0.0069	0.0069	CcSEcCtD
Benzatropine—Hypersensitivity—Bleomycin—testicular cancer	0.00689	0.00689	CcSEcCtD
Benzatropine—Constipation—Ifosfamide—testicular cancer	0.00684	0.00684	CcSEcCtD
Benzatropine—Cerebrovascular accident—Doxorubicin—testicular cancer	0.0068	0.0068	CcSEcCtD
Benzatropine—Tachycardia—Cisplatin—testicular cancer	0.00673	0.00673	CcSEcCtD
Benzatropine—Feeling abnormal—Ifosfamide—testicular cancer	0.00659	0.00659	CcSEcCtD
Benzatropine—Nausea—Vinblastine—testicular cancer	0.00658	0.00658	CcSEcCtD
Benzatropine—Hypersensitivity—Dactinomycin—testicular cancer	0.00643	0.00643	CcSEcCtD
Benzatropine—Confusional state—Etoposide—testicular cancer	0.00637	0.00637	CcSEcCtD
Benzatropine—Body temperature increased—Ifosfamide—testicular cancer	0.00632	0.00632	CcSEcCtD
Benzatropine—Dysphagia—Epirubicin—testicular cancer	0.00623	0.00623	CcSEcCtD
Benzatropine—Dysuria—Methotrexate—testicular cancer	0.00622	0.00622	CcSEcCtD
Benzatropine—Tachycardia—Etoposide—testicular cancer	0.00616	0.00616	CcSEcCtD
Benzatropine—Decreased appetite—Cisplatin—testicular cancer	0.00599	0.00599	CcSEcCtD
Benzatropine—Vomiting—Bleomycin—testicular cancer	0.00595	0.00595	CcSEcCtD
Benzatropine—Rash—Bleomycin—testicular cancer	0.0059	0.0059	CcSEcCtD
Benzatropine—Dermatitis—Bleomycin—testicular cancer	0.00589	0.00589	CcSEcCtD
Benzatropine—Hypersensitivity—Ifosfamide—testicular cancer	0.00589	0.00589	CcSEcCtD
Benzatropine—Dysuria—Epirubicin—testicular cancer	0.00582	0.00582	CcSEcCtD
Benzatropine—Dysphagia—Doxorubicin—testicular cancer	0.00576	0.00576	CcSEcCtD
Benzatropine—Feeling abnormal—Cisplatin—testicular cancer	0.00568	0.00568	CcSEcCtD
Benzatropine—Nausea—Bleomycin—testicular cancer	0.00556	0.00556	CcSEcCtD
Benzatropine—Vomiting—Dactinomycin—testicular cancer	0.00555	0.00555	CcSEcCtD
Benzatropine—Rash—Dactinomycin—testicular cancer	0.0055	0.0055	CcSEcCtD
Benzatropine—Decreased appetite—Etoposide—testicular cancer	0.00549	0.00549	CcSEcCtD
Benzatropine—Body temperature increased—Cisplatin—testicular cancer	0.00545	0.00545	CcSEcCtD
Benzatropine—Constipation—Etoposide—testicular cancer	0.0054	0.0054	CcSEcCtD
Benzatropine—Dysuria—Doxorubicin—testicular cancer	0.00539	0.00539	CcSEcCtD
Benzatropine—Feeling abnormal—Etoposide—testicular cancer	0.0052	0.0052	CcSEcCtD
Benzatropine—Nausea—Dactinomycin—testicular cancer	0.00518	0.00518	CcSEcCtD
Benzatropine—Vomiting—Ifosfamide—testicular cancer	0.00508	0.00508	CcSEcCtD
Benzatropine—Hypersensitivity—Cisplatin—testicular cancer	0.00508	0.00508	CcSEcCtD
Benzatropine—Rash—Ifosfamide—testicular cancer	0.00504	0.00504	CcSEcCtD
Benzatropine—Dermatitis—Ifosfamide—testicular cancer	0.00504	0.00504	CcSEcCtD
Benzatropine—Body temperature increased—Etoposide—testicular cancer	0.00499	0.00499	CcSEcCtD
Benzatropine—Hypoaesthesia—Epirubicin—testicular cancer	0.00496	0.00496	CcSEcCtD
Benzatropine—Nausea—Ifosfamide—testicular cancer	0.00475	0.00475	CcSEcCtD
Benzatropine—Hypersensitivity—Etoposide—testicular cancer	0.00465	0.00465	CcSEcCtD
Benzatropine—Hypoaesthesia—Doxorubicin—testicular cancer	0.00459	0.00459	CcSEcCtD
Benzatropine—Vomiting—Cisplatin—testicular cancer	0.00438	0.00438	CcSEcCtD
Benzatropine—Vision blurred—Methotrexate—testicular cancer	0.00437	0.00437	CcSEcCtD
Benzatropine—Rash—Cisplatin—testicular cancer	0.00435	0.00435	CcSEcCtD
Benzatropine—Dermatitis—Cisplatin—testicular cancer	0.00434	0.00434	CcSEcCtD
Benzatropine—Tension—Epirubicin—testicular cancer	0.00426	0.00426	CcSEcCtD
Benzatropine—Nervousness—Epirubicin—testicular cancer	0.00421	0.00421	CcSEcCtD
Benzatropine—Nausea—Cisplatin—testicular cancer	0.00409	0.00409	CcSEcCtD
Benzatropine—Vision blurred—Epirubicin—testicular cancer	0.00409	0.00409	CcSEcCtD
Benzatropine—Vomiting—Etoposide—testicular cancer	0.00402	0.00402	CcSEcCtD
Benzatropine—Rash—Etoposide—testicular cancer	0.00398	0.00398	CcSEcCtD
Benzatropine—Dermatitis—Etoposide—testicular cancer	0.00398	0.00398	CcSEcCtD
Benzatropine—Tension—Doxorubicin—testicular cancer	0.00394	0.00394	CcSEcCtD
Benzatropine—Nervousness—Doxorubicin—testicular cancer	0.0039	0.0039	CcSEcCtD
Benzatropine—Confusional state—Methotrexate—testicular cancer	0.00381	0.00381	CcSEcCtD
Benzatropine—Vision blurred—Doxorubicin—testicular cancer	0.00378	0.00378	CcSEcCtD
Benzatropine—Nausea—Etoposide—testicular cancer	0.00375	0.00375	CcSEcCtD
Benzatropine—Dry mouth—Epirubicin—testicular cancer	0.00361	0.00361	CcSEcCtD
Benzatropine—Confusional state—Epirubicin—testicular cancer	0.00357	0.00357	CcSEcCtD
Benzatropine—Tachycardia—Epirubicin—testicular cancer	0.00346	0.00346	CcSEcCtD
Benzatropine—Dry mouth—Doxorubicin—testicular cancer	0.00334	0.00334	CcSEcCtD
Benzatropine—Confusional state—Doxorubicin—testicular cancer	0.0033	0.0033	CcSEcCtD
Benzatropine—Decreased appetite—Methotrexate—testicular cancer	0.00329	0.00329	CcSEcCtD
Benzatropine—Tachycardia—Doxorubicin—testicular cancer	0.0032	0.0032	CcSEcCtD
Benzatropine—Feeling abnormal—Methotrexate—testicular cancer	0.00312	0.00312	CcSEcCtD
Benzatropine—Decreased appetite—Epirubicin—testicular cancer	0.00308	0.00308	CcSEcCtD
Benzatropine—Constipation—Epirubicin—testicular cancer	0.00303	0.00303	CcSEcCtD
Benzatropine—Body temperature increased—Methotrexate—testicular cancer	0.00299	0.00299	CcSEcCtD
Benzatropine—Feeling abnormal—Epirubicin—testicular cancer	0.00292	0.00292	CcSEcCtD
Benzatropine—Decreased appetite—Doxorubicin—testicular cancer	0.00285	0.00285	CcSEcCtD
Benzatropine—Constipation—Doxorubicin—testicular cancer	0.0028	0.0028	CcSEcCtD
Benzatropine—Body temperature increased—Epirubicin—testicular cancer	0.0028	0.0028	CcSEcCtD
Benzatropine—Hypersensitivity—Methotrexate—testicular cancer	0.00279	0.00279	CcSEcCtD
Benzatropine—Feeling abnormal—Doxorubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Benzatropine—Hypersensitivity—Epirubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Benzatropine—Body temperature increased—Doxorubicin—testicular cancer	0.00259	0.00259	CcSEcCtD
Benzatropine—Hypersensitivity—Doxorubicin—testicular cancer	0.00241	0.00241	CcSEcCtD
Benzatropine—Vomiting—Methotrexate—testicular cancer	0.00241	0.00241	CcSEcCtD
Benzatropine—Rash—Methotrexate—testicular cancer	0.00239	0.00239	CcSEcCtD
Benzatropine—Dermatitis—Methotrexate—testicular cancer	0.00238	0.00238	CcSEcCtD
Benzatropine—Vomiting—Epirubicin—testicular cancer	0.00225	0.00225	CcSEcCtD
Benzatropine—Nausea—Methotrexate—testicular cancer	0.00225	0.00225	CcSEcCtD
Benzatropine—Rash—Epirubicin—testicular cancer	0.00223	0.00223	CcSEcCtD
Benzatropine—Dermatitis—Epirubicin—testicular cancer	0.00223	0.00223	CcSEcCtD
Benzatropine—Nausea—Epirubicin—testicular cancer	0.0021	0.0021	CcSEcCtD
Benzatropine—Vomiting—Doxorubicin—testicular cancer	0.00208	0.00208	CcSEcCtD
Benzatropine—Rash—Doxorubicin—testicular cancer	0.00207	0.00207	CcSEcCtD
Benzatropine—Dermatitis—Doxorubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Benzatropine—Nausea—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
